Amundi - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Amundi ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$212,422
-4.1%
26,586
+55.8%
0.00%
Q2 2023$221,504
+403.4%
17,065
+566.1%
0.00%
Q3 2022$44,000
-10.2%
2,562
+51.8%
0.00%
Q4 2021$49,0001,6880.00%
Other shareholders
PULMONX CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$1,003,0006.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,720,901$61,990,0001.23%
NEXT CENTURY GROWTH INVESTORS LLC 454,614$7,573,0000.92%
PURA VIDA INVESTMENTS, LLC 778,978$12,978,0000.75%
Novo Holdings A/S 510,555$8,506,0000.41%
Champlain Investment Partners, LLC 2,802,460$46,689,0000.32%
TimesSquare Capital Management, LLC 1,223,754$20,388,0000.28%
Rock Springs Capital Management LP 597,400$9,953,0000.26%
HAMILTON LANE ADVISORS LLC 29,150$486,0000.18%
RTW INVESTMENTS, LP 460,847$7,678,0000.18%
View complete list of PULMONX CORP shareholders